Jaeyun Sung

Dr. Jaeyun Sung (MS 08, PhD 12) is a computational systems biologist and precision medicine researcher at Mayo Clinic, where he is an Associate Professor of Biomedical Informatics and leads the Computational Precision Medicine & Surgery Laboratory. His research group specializes in high-throughput biomolecular data ("omics”) and medical imaging analysis, tackling clinically urgent challenges in a range of chronic conditions, including autoimmune inflammatory disorder, neurodegenerative disease, and cancer.

Sung earned a B.S. in Chemical Engineering from the Georgia Institute of Technology (2006) and an M.S. (2008) and Ph.D. (2012) from the University of Illinois Urbana-Champaign. He completed postdoctoral fellowships at the Asia-Pacific Center for Theoretical Physics in South Korea and at Harvard Medical School before joining Mayo Clinic. His honors include selection as a Scialog Fellow by the Research Corporation for Science Advancement and as a Diversity Scholar in the NIH/NIA CLEAR-AD U19 program. Beyond his academic research, he serves as scientific advisor and patent licensor to Rheumasense Dx Inc., an early-stage precision medicine company working to improve care for patients with rheumatoid arthritis, and is Co-Founder, Chief Technology Officer, and Vice President of NaviNetics AI, a Mayo Clinic spin-off startup developing AI-guided software and robotics for neurosurgery.

Across his academic and entrepreneurial work, Sung is committed to turning computational innovation into technology that improves patient care and shapes the future of precision medicine.